Research Triangle Park, NC, United States of America

Lita S Suwandi

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lita S Suwandi: Innovator in Viral Infection Treatment

Introduction

Lita S Suwandi is a prominent inventor based in Research Triangle Park, NC (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating viral infections. With a total of three patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Lita's latest patents include innovative compounds that target viral infections. One of her notable patents involves benzoazepine derivatives, which disclose compounds of Formula I and methods for treating viral infections using compositions that include these compounds. Another significant patent focuses on isoindoline derivatives, also aimed at treating viral infections, detailing compounds of Formula I and their therapeutic applications.

Career Highlights

Lita is currently employed at ViiV Healthcare UK Limited, where she continues to advance her research in antiviral therapies. Her work is characterized by a commitment to developing effective treatments that can improve patient outcomes in the face of viral challenges.

Collaborations

Lita has collaborated with esteemed colleagues, including Brian Alvin Johns and Emile Johann Velthuisen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Lita S Suwandi's contributions to the field of antiviral treatments through her patents and collaborative efforts highlight her role as a leading inventor in the healthcare sector. Her work continues to pave the way for advancements in the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…